What does Pacific Biosciences of California, Inc. do?

Jun 22 2025 06:17 PM IST
share
Share Via
Pacific Biosciences of California, Inc. designs and manufactures genetic sequencing systems in the Pharmaceuticals & Biotechnology industry. As of March 2025, it reported net sales of $37 million and a net loss of $426 million, with a market cap of $390.11 million.
Overview:
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems for genetic analysis, operating within the Pharmaceuticals & Biotechnology industry and categorized as a Micro Cap company.

Financial Snapshot:
Net Sales: 37 Million (Quarterly Results - Mar 2025)
Net Profit: -426 Million (Quarterly Results - Mar 2025)
Market cap: USD 390.11 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: 3.33
Return on Equity: -650.30%
Price to Book: 4.26

Contact Details:
Address: 1305 O'brien Drive, MENLO PARK CA: 94025
Tel: 1 650 5218000
Fax: 1 302 6365454
Website: https://www.pacb.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News